BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17522406)

  • 1. Prevention of death in COPD.
    Barnes PJ
    N Engl J Med; 2007 May; 356(21):2211; author reply 2213-4. PubMed ID: 17522406
    [No Abstract]   [Full Text] [Related]  

  • 2. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of death in COPD.
    Duerden M
    N Engl J Med; 2007 May; 356(21):2212; author reply 2213-4. PubMed ID: 17526087
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of death in COPD.
    La Vecchia C; Fabbri LM
    N Engl J Med; 2007 May; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of death in COPD.
    Kupfer Y; Tessler S
    N Engl J Med; 2007 May; 356(21):2212-3; author reply 2213-4. PubMed ID: 17526086
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
    Doherty DE; Chapman KR; Martinez FJ; Belfer MH
    J Fam Pract; 2007 Oct; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined salmeterol and fluticasone for COPD.
    Vassiliou V
    Lancet; 2003 May; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic obstructive pulmonary disease. No increased survival with combination therapy].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2007 Nov; 30(11):428-9. PubMed ID: 18062342
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
    Hackam DG
    CMAJ; 2003 May; 168(10):1296-7. PubMed ID: 12743078
    [No Abstract]   [Full Text] [Related]  

  • 12. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec; 16(92):257-8. PubMed ID: 18092426
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
    Holt S; Masoli M; Beasley R
    J Allergy Clin Immunol; 2004 Feb; 113(2):219-20. PubMed ID: 14767433
    [No Abstract]   [Full Text] [Related]  

  • 15. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Yates JC; Vestbo J;
    N Engl J Med; 2007 Feb; 356(8):775-89. PubMed ID: 17314337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec; 17(98):229. PubMed ID: 19418648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined salmeterol and fluticasone for COPD.
    Khamis RY; Rajakulasingam RK
    Lancet; 2003 May; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
    Marchand E
    Rev Mal Respir; 2010 Feb; 27(2):125-40. PubMed ID: 20206061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S
    Am J Respir Crit Care Med; 2008 Aug; 178(4):322-3. PubMed ID: 18676961
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.